Source: Medthority

OPKO: OPKO and Entera Bio Collaboration

OPKO Health and Entera Bio collaborate to advance oral dual-agonist GLP-1/glucagon peptide for obesity treatment.

Read full article »
OPKO's Competitors | OPKO's News | OPKO's Financials
Stay up-to-date with the latest news on OPKO
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
Phillip Frost's photo - Chairman & CEO of OPKO

Chairman & CEO

Phillip Frost

CEO Approval Rating

92/100

Read more
Stay up-to-date with the latest news on OPKO